Healthcare & Life Sciences
XERIS Pharmaceuticals
United States
acquiredacquired
acquired
Stage
2
Investors
About
XERIS Pharmaceuticals develops proprietary injectable formulation technologies enabling the subcutaneous and intradermal delivery of peptides, proteins, antibodies, and small molecules with improved stability and reduced injection volumes.
Explore XERIS Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.